Halozyme Therapeutics, Inc. (HALO)

Halozyme Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Cash & Equivalents	163.14	309.75	133.82	419.67	61.86	176.33	115.85	154.32	187.86	164.63	118.37	274.23	221.17	96.38	234.2	147.16	90.93	117.84	118.72	491.68
Short-Term Investments	67.87	8.87	9	282.3	486.32	571.59	480.22	511.99	341.17	298.82	217.63	209.06	127.11	179.23	128.6	118.43	118.43	668.31	622.2	324.24
Cash & Short-Term Investments	231	318.62	142.82	701.96	548.18	747.92	596.07	666.31	529.03	463.45	336	483.28	348.28	275.61	362.79	265.58	209.36	786.14	740.92	815.92
Cash Growth (YoY)	-57.86%	-57.40%	-76.04%	5.35%	3.62%	61.38%	77.40%	37.87%	51.90%	68.16%	-7.38%	81.97%	66.35%	-64.94%	-51.03%	-67.45%	-72.28%	2.86%	101.33%	135.34%
Accounts Receivable	455.83	457.99	439.66	346.04	316.34	304.62	308.46	285.74	214.52	195.9	234.21	217.33	245.94	194.88	231.07	223.32	179.38	113.76	90.98	112.1
Other Receivables	-	-	1.61	-	-	-	-	-	-	-	-	-	0.24	-	-	9.99	9.99	-	-	-
Receivables	455.83	457.99	441.27	346.04	316.34	304.62	308.46	285.74	214.52	195.9	234.21	217.33	246.18	194.88	231.07	233.3	189.37	113.76	90.98	112.1
Inventory	137.14	155.47	176.48	185.8	181.51	164.87	141.86	131.41	159.31	168.54	127.6	128.92	132.41	107.52	100.12	103.28	97.62	47.76	53.91	55.98
Prepaid Expenses	108.26	70.56	64.64	94.96	76.65	44.62	38.95	43.52	84.93	45.69	48.61	49.48	38.89	37.01	45.02	51.04	45.6	41.03	40.48	33.3
Other Current Assets	0.8	0.4	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	933.02	1,003	825.21	1,329	1,123	1,262	1,085	1,127	987.8	873.58	746.42	879.01	765.75	615.02	739.01	653.2	541.94	988.69	926.29	1,017
Property, Plant & Equipment	84.27	82.23	82.14	71.42	71.52	72.82	75.04	74.49	75	78.07	74.94	74.67	74.56	77.96	75.57	36.67	37.09	8.51	8.79	9.59
Goodwill	581.73	582.32	580.36	416.82	416.82	416.82	416.82	416.82	416.82	416.82	416.82	416.82	416.82	416.22	409.05	199.48	199.48	-	-	-
Other Intangible Assets	922.44	951.96	981.47	348.54	366.31	384.07	401.83	419.59	437.35	455.12	472.88	490.64	510.98	528.82	546.65	948.9	976.1	-	-	-
Long-Term Deferred Tax Assets	-	-	-	-	20.21	5.19	3.86	-	-	0.62	4.39	13.41	23.92	35.68	44.43	-	-	142.51	155.43	142.48
Other Long-Term Assets	55.94	53.18	56.15	55.7	56.37	55.61	80.6	80.15	52.48	17.32	17.82	18.12	18.41	25.74	26.8	26.28	26.78	22.54	13.91	16.05
Total Assets	2,577	2,673	2,525	2,221	2,054	2,197	2,063	2,118	1,969	1,842	1,733	1,893	1,810	1,699	1,842	1,865	1,781	1,162	1,104	1,185

Liabilities

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Accounts Payable	23.61	14.1	20.9	15.36	18.69	20.07	10.25	12.4	15.43	13.33	11.82	19.32	10.12	8.7	17.69	18.17	12.23	1.27	1.54	3.32
Accrued Expenses	111.86	140.37	144.92	111.18	115.59	130.31	128.85	96.42	45.86	58.74	100.68	36.78	54.92	43.24	97.66	62.92	81.86	17.1	22.17	16.52
Current Portion of Long-Term Debt	208.97	208.74	-	710.69	-	-	-	-	-	-	-	-	-	-	13.33	13.32	99.05	89.55	89.42	89.25
Current Portion of Leases	-	-	11.28	-	-	-	-	-	0.16	0.56	-	3.94	2.72	4.49	2.1	1.99	2.24	2.03	2.28	1.82
Current Income Taxes Payable	-	-	-	-	-	-	-	-	29.27	19.07	-	18.03	7.94	2.64	-	9.41	-	-	-	-
Current Unearned Revenue	-	-	-	-	-	-	-	-	-	-	-	0.67	0.84	3.25	-	3.59	4.13	1.75	1.75	2.25
Other Current Liabilities	-	-	-	-	-	-	-	-	42.65	39.94	-	36.46	39.86	29.61	-	-	-	-	-	-
Total Current Liabilities	344.44	363.21	177.09	837.23	134.28	150.38	139.1	108.82	133.36	131.64	112.49	115.19	116.39	91.92	130.79	109.38	199.51	111.69	117.15	113.15
Long-Term Debt	1,938	1,936	2,143	800.07	1,509	1,507	1,506	1,504	1,503	1,501	1,499	1,498	1,496	1,494	1,493	1,491	1,147	788.1	787.26	786.45
Long-Term Leases	31.88	32.42	23.29	28.1	28.97	29.39	-	30.76	30.51	31.2	32.2	28.42	30.88	29.57	32.69	5.42	5.55	0.17	0.54	1.61
Long-Term Unearned Revenue	-	-	-	-	-	-	-	-	-	-	-	2.25	2.25	2.25	-	2.83	2.74	2.03	2.53	2.53
Long-Term Deferred Tax Liabilities	49.06	47.53	42.92	8.22	-	-	-	11.95	13.65	-	-	-	-	-	-	28.99	3.29	-	-	-
Other Long-Term Liabilities	70.8	74.03	90.57	43.7	48.8	27.05	54.76	9.65	-	-	5.52	-	13.89	15.47	15.47	129.77	130	-	-	-
Total Liabilities	2,434	2,453	2,477	1,717	1,721	1,714	1,700	1,665	1,680	1,664	1,649	1,643	1,659	1,634	1,672	1,768	1,488	901.99	907.48	903.75

Shareholders' Equity

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Common Stock	0.11	0.12	0.12	0.12	0.12	0.12	0.12	0.13	0.13	0.13	0.13	0.13	0.13	0.13	0.14	0.14	0.14	0.14	0.14	0.14
Additional Paid-In Capital	-	27.39	12	23.91	-	7.6	-	61.89	30.75	11.79	2.41	25.54	12.07	-	27.37	13.18	271.17	261.71	256.35	407.23
Retained Earnings	151.26	204.84	54.79	502.15	361.03	477.96	359.87	397.63	260.62	167.37	90.55	222.29	140.45	65.69	143.22	85.52	23.88	1.2	-58.91	-125.68
Comprehensive Income & Other	-7.83	-12.7	-18.09	-22.26	-28.4	-3.41	3.83	-6.94	-2.07	-1.49	-9.28	1.23	-1.62	0.02	-0.92	-1.84	-2.02	-2.79	-0.62	-0.01
Shareholders' Equity	143.54	219.64	48.81	503.92	332.75	482.27	363.82	452.7	289.42	177.81	83.81	249.18	151.03	65.85	169.8	96.99	293.17	260.26	196.95	281.67
Total Liabilities & Equity	2,577	2,673	2,525	2,221	2,054	2,197	2,063	2,118	1,969	1,842	1,733	1,893	1,810	1,699	1,842	1,865	1,781	1,162	1,104	1,185

Additional Metrics

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Total Debt	2,179	2,177	2,177	1,539	1,538	1,537	1,506	1,535	1,533	1,533	1,531	1,530	1,530	1,528	1,541	1,512	1,254	879.85	879.49	879.13
Net Cash (Debt)	-1,948	-1,858	-2,034	-836.9	-989.89	-788.91	-909.72	-868.6	-1,004	-1,069	-1,195	-1,047	-1,181	-1,253	-1,178	-1,246	-1,045	-93.71	-138.57	-63.21
Net Cash Growth (YoY)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Cash Per Share	-16.07	-15.12	-17.29	-6.84	-7.97	-6.23	-7.05	-6.67	-7.77	-8.30	-9.12	-7.81	-8.85	-9.09	-8.50	-8.94	-7.35	-0.66	-0.96	-0.43
Filing Date Shares Outstanding	113.5	118.61	118.02	117.6	116.97	123.22	123.15	127.23	126.68	127.27	126.82	132.1	131.92	131.68	135.37	135.21	137.78	137.95	137.7	140.73
Total Common Shares Outstanding	114.04	118.52	117.78	117.52	117.62	123.17	123.14	127.18	126.54	127.19	126.77	132.08	131.86	131.66	135.15	135.21	137.68	137.89	137.5	140.9
Working Capital	588.59	639.83	648.12	491.52	988.39	1,112	946.24	1,018	854.44	741.95	633.93	763.82	649.35	523.1	608.22	543.82	342.43	877	809.14	904.15
Book Value Per Share	1.26	1.85	0.41	4.29	2.83	3.92	2.95	3.56	2.29	1.40	0.66	1.89	1.15	0.50	1.26	0.72	2.13	1.89	1.43	2.00
Tangible Book Value	-1,361	-1,315	-1,513	-261.45	-450.38	-318.62	-454.83	-383.71	-564.75	-694.13	-805.89	-658.28	-776.77	-879.19	-785.9	-1,051	-882.41	260.26	196.95	281.67
Tangible Book Value Per Share	-11.93	-11.09	-12.85	-2.22	-3.83	-2.59	-3.69	-3.02	-4.46	-5.46	-6.36	-4.98	-5.89	-6.68	-5.81	-7.78	-6.41	1.89	1.43	2.00
Machinery	73.62	72.68	68.2	61.96	61.46	60.25	57.53	56.79	55.41	55.94	50.78	48.7	46.02	48.02	43.13	36.56	36.3	18.19	18.26	18.14
Leasehold Improvements	7.52	7.52	7.52	7.43	7.35	7.2	7.01	7	7.04	7.12	6.99	6.86	6.61	6.7	6.73	9.59	8.82	1.75	1.63	1.63
Order Backlog	234.3	265.8	-	260.9	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 6, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 29, 2026

Data Sources Report a data error